会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • SYSTEM AND METHOD FOR ENERGY STORAGE AND RECOVERY
    • 能量储存和恢复系统与方法
    • US20130183597A1
    • 2013-07-18
    • US13700095
    • 2011-05-24
    • Uday B. PalSrikanth Gopalan
    • Uday B. PalSrikanth Gopalan
    • H01M8/12H01M8/06
    • H01M8/12C25B1/04C25B11/0457C25B15/08H01M8/0656H01M8/0662H01M8/186H01M2008/1293Y02E60/366Y02E60/528
    • System and method for energy storage and recovery is described. More particularly, system and method using tungsten based materials to electrochemically store and recover energy is described. In certain embodiments, the system includes a reversible solid oxide electrochemical cell (RSOEC) having a porous cathode, a porous anode, and an electrolyte capable of transporting oxygen ion. The system further includes a reactor comprising tungsten, tungsten oxide, or combinations thereof. To store the energy, the RSOEC is capable of receiving electricity to electrolyze H2O to generate H2 and O2 and the reactor is operably connected to the RSOEC to receive the generated H2 and convert tungsten oxide to tungsten thereby storing electrical energy. To recover the energy, reactor is capable of receiving H2O to convert tungsten to tungsten oxide and generate H2 and the RSOEC is operably connected to the reactor to receive the generated H2 and generate electrical energy.
    • 描述了用于储能和回收的系统和方法。 更具体地,描述了使用钨基材料电化学存储和回收能量的系统和方法。 在某些实施方案中,该系统包括具有多孔阴极,多孔阳极和能够输送氧离子的电解质的可逆固体氧化物电化学电池(RSOEC)。 该系统还包括包含钨,氧化钨或其组合的反应器。 为了存储能量,RSOEC能够接收电以电解H 2 O以产生H 2和O 2,并且反应器可操作地连接到RSOEC以接收所产生的H 2并将氧化钨转换成钨从而存储电能。 为了回收能量,反应器能够接收H 2 O以将钨转化为氧化钨并产生H 2并且RSOEC可操作地连接到反应器以接收生成的H 2并产生电能。
    • 10. 发明申请
    • Detection Of Disease Related Genes
    • 疾病相关基因检测
    • US20120190035A1
    • 2012-07-26
    • US13437589
    • 2012-04-02
    • Kenneth J. RothschildSanjay M. SonarJerzy Olejnik
    • Kenneth J. RothschildSanjay M. SonarJerzy Olejnik
    • C12Q1/68
    • A61K41/0042A61K38/00C07C205/45C07C205/57C07D207/404C07D311/16C07D405/12C07D495/04C07H19/04C07H21/00C07K1/1077C07K1/13C12P21/00C12Q1/6883G01N33/58
    • The invention is directed to methods for the non-radioactive labeling, detection, quantitation and isolation of nascent proteins translated in a cellular or cell-free translation system. tRNA molecules are misaminoacylated with non-radioactive markers which may be non-native amino acids, amino acid analogs or derivatives, or substances recognized by the protein synthesizing machinery. Markers may comprise cleavable moieties, detectable labels, reporter properties wherein markers incorporated into protein can be distinguished from unincorporated markers, or coupling agents which facilitate the detection and isolation of nascent protein from other components of the translation system. The invention also comprises proteins prepared using misaminoacylated tRNAs which can be utilized in pharmaceutical compositions for the treatment of diseases and disorders in humans and other maninials, and kits which may be used for the detection of diseases and disorders.
    • 本发明涉及用于在细胞或无细胞翻译系统中翻译的新生蛋白的非放射性标记,检测,定量和分离的方法。 tRNA分子被非放射性标记物错氨基酰化,其可以是非天然氨基酸,氨基酸类似物或衍生物,或由蛋白质合成机理识别的物质。 标记可以包含可切割部分,可检测标记,报告基因特性,其中掺入蛋白质的标记可以与非组合标记物或促进从翻译系统的其他组分检测和分离新生蛋白质的偶联剂区别。 本发明还包括使用可以用于治疗人类和其他肌肉疾病和病症的药物组合物中的使用错氨基酰化tRNA制备的蛋白质,以及可用于检测疾病和病症的试剂盒。